KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Depreciation & Amortization (CF): 2010-2025

Historic Depreciation & Amortization (CF) for Exelixis (EXEL) over the last 14 years, with Oct 2025 value amounting to $7.4 million.

  • Exelixis' Depreciation & Amortization (CF) fell 0.43% to $7.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $29.8 million, marking a year-over-year increase of 7.45%. This contributed to the annual value of $28.8 million for FY2025, which is 12.00% up from last year.
  • As of Q4 2025, Exelixis' Depreciation & Amortization (CF) stood at $7.4 million, which was up 1.09% from $7.3 million recorded in Q3 2025.
  • Exelixis' Depreciation & Amortization (CF)'s 5-year high stood at $7.6 million during Q1 2025, with a 5-year trough of $1.9 million in Q4 2021.
  • Over the past 3 years, Exelixis' median Depreciation & Amortization (CF) value was $7.3 million (recorded in 2024), while the average stood at $7.0 million.
  • As far as peak fluctuations go, Exelixis' Depreciation & Amortization (CF) slumped by 36.75% in 2021, and later skyrocketed by 207.92% in 2022.
  • Exelixis' Depreciation & Amortization (CF) (Quarterly) stood at $1.9 million in 2021, then skyrocketed by 207.92% to $5.9 million in 2022, then rose by 9.75% to $6.5 million in 2023, then increased by 18.39% to $7.5 million in 2024, then fell by 0.43% to $7.4 million in 2025.
  • Its Depreciation & Amortization (CF) was $7.4 million in Q4 2025, compared to $7.3 million in Q3 2025 and $7.3 million in Q2 2025.